Psychedelic Stock IPO the Next 1,000% Gain?

Psychedelic stocks are quickly emerging as a red-hot sector.

Need evidence?

Take a look at Mind Medicine (NASDAQ: MNMD), a promising young biotech headquartered in New York, New York, that specializes in developing psychedelic drug therapies.

Shares were just uplisted from over-the-counter (OTC) markets to the NASDAQ stock exchange, and this stock is now up more than 1,000% in the last nine months. Continue reading “Psychedelic Stock IPO the Next 1,000% Gain?”